Immodulon Therapeutics immodulon.com


Public list: Pharma Startups (4733) Cancer Therapeutics (1133)

Immodulon is a biopharmaceutical company pioneering immunotherapy cancer treatments - an approach now recognized as the biggest breakthrough since chemotherapy.

Immodulon is a biopharmaceutical company pioneering immunotherapy cancer treatments - an approach now recognized as the biggest breakthrough since chemotherapy.

Company (Alive / Active)

Phone: +44 (0) 20 3137 6346

Fax:

6-9 The Square
Stockley Park
Uxbridge, UB11 1FW
United Kingdom

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Immodulon Therapeutics $0.7M Jun 1, 2015

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Immodulon Therapeutics Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 1 investors
There is no Board of Directors data available for this company. Please select another tab.
There is no Competitors data available for this company. Please select another tab.

Patents

Title Application Date Patent Date Status
(Patent / Application)
Cancer therapy Feb 15, 2012 Dec 31, 2013 Patent
A checkpoint inhibitor and a whole cell mycobacterium for use in cancer therapy Dec 16, 2014 Application
Cancer therapy May 09, 2014 Application
Treatment of post-traumatic stress disorder with isolated mycobacterium Sep 17, 2013 Application
Immunogenic treatment of cancer Dec 03, 2012 Application